Trials / Completed
CompletedNCT00667173
A Clinical Study Evaluating the Safety and Efficacy of IDP-115 in Patients With Rosacea
A Phase 2, Multi-Center, Evaluator-Blind, Randomized, Vehicle-Controlled Clinical Study to Assess the Safety and Efficacy of IDP-115 in the Treatment of Rosacea
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- Dow Pharmaceutical Sciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and effectiveness of IDP-115 in treating patients with rosacea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IDP-115 | Topical application for 12 weeks |
| DRUG | Vehicle | Topical application for 12 weeks |
| DRUG | Vehicle | Topical application for 12 weeks |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2008-04-25
- Last updated
- 2012-02-20
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00667173. Inclusion in this directory is not an endorsement.